BMS, Novartis Sue Teva Over HIV Drug Reyataz
Bristol Myers-Squibb Co. and Novartis Corp. have sued generic-drug maker Teva Pharmaceuticals USA Inc. over its attempt to introduce its own version of HIV treatment Reyataz before the drug's patents expire....To view the full article, register now.
Already a subscriber? Click here to view full article